{"article_title": "What were people thinking when they backed Theranos? Could it get worse for Valeant?MedCity News", "article_keywords": ["wants", "worse", "theranos", "thinking", "company", "million", "pfizer", "york", "health", "systems", "healthcare", "backed", "medical", "valeantmedcity", "care"], "article_url": "http://medcitynews.com/2016/04/abbott-laboratories-and-st-jude-medical/", "article_text": "TOP STORIES\n\nAbbott has agreed to acquire cardiac medical device maker St. Jude Medical in a deal valued at $25 billion. The move is part of a wider consolidation trend among device makers to gain more clout in negotiating contracts with hospitals. The combined company\u2019s product development pipeline not only includes cardiovascular devices, but also diabetes and neuromodulation patient care. \u2014 Bloomberg, Abbott\n\n\u201cNow that failed inspections, government sanctions and a criminal investigation have shadowed the once stellar expectations surrounding the blood-testing company Theranos, the big question is turning from whether the company will eventually prevail to why so many people were so enamored of it in the first place.\u201d \u2014 Bloomberg\n\nLIFE SCIENCES\n\nSpeaking of embattled companies, the future of Valeant Pharmaceuticals \u201cremains dim,\u201d despite departing CEO Michael Pearson\u2019s mea culpa to Congress Wednesday. The future starts by cleaning house on its board. \u2014 STAT, The Wall Street Journal\n\nWhile we\u2019re piling on, Pfizer will pay $784.6 million to settle Medicaid fraud charges tied to Wyeth, a company Pfizer bought in 2009. Two whistleblowers will share $98 million of that total. \u2014 Reuters\n\nDr. Patrick Soon-Shiong received $147.6 million in pay for 2015 from NantKwest, the highest reported for any public company\u2019s executive to date. \u2014 Bloomberg\n\nThe FDA requested more information from Otsuka Pharmaceutical and Proteus Digital Health about their combined \u201csmart pill\u201d version of the antidepressant Abilify. \u2014 MassDevice\n\nThe latest advancement in CRISPR-Cas9 technology solves the \u201cEnergizer bunny\u201d problem in gene editing and lets geneticists edit just one copy of each gene. \u2014 STAT\n\nNew Illumina CEO Francis deSouza wants to raise the profile of his company, which has a $22 billion market capitalization but lacks the name recognition of 23andMe. \u2014 Fast Company\n\nMicrosoft will purchase 10 million strands of lab-made DNA strands from startup Twist Bioscience, apparently to store lots of data for hundreds of years. \u2014 Business Insider\n\nBiogen has poached a Pfizer executive to run its R&D operations. \u2014 BioSpace\n\nPAYERS-PROVIDERS\n\nGeisinger Health System has had such demand for a study on combining genomics and EHRs that it\u2019s raising its target to 250,000 participants. \u2014 Healthcare IT News\n\nWhile UnitedHealthcare bails on Affordable Care Act exchanges, Anthem Chairman Joe Swedish still believes \u201ca sustainable model can be built.\u201d \u2014 Forbes\n\nSeven types of procedures account for 80 percent of all deaths in emergency general surgery, according to a new study. \u2014 HealthDay via WebMD\n\nThe five major health systems in the Milwaukee area have formed an alliance to build the local healthcare workforce. \u2014 Milwaukee Journal Sentinel\n\nPartners HealthCare has announced its second annual \u201cDisruptive Dozen\u201d technologies that could transform cancer care in the next decade. \u2014 Business Wire\n\nTECHNOLOGY\n\nMajor health systems share their strategies for fighting ransomware. \u2014 HIStalk\n\nHealth analytics company CloudMedx has acquired startup Gyrus Labs. \u2014 Marketwired\n\nHealthvana, the app-maker that connects people to STD testing, gets some love from the mainstream media for its HIV educational programs. \u2014 The New York Times\n\nPOLITICS\n\nHouse Speaker Paul Ryan (R-Wisconsin) wants to end the ACA\u2019s financial protections for people with serious medical conditions and move affected patients to high-risk insurance pools at the state level. \u2014 Reuters\n\nSen. Ron Wyden (D-Oregon) has introduced a bill to cap drug cost-sharing for Medicare beneficiaries. \u2014 The Hill\n\nA LITTLE BIT EXTRA\n\nRemember when the American Medical Association used to be chummy with Big Tobacco and accept cigarette ads in JAMA? Britain\u2019s Royal College of Physicians now is cool with vaping. \u2014 The New York Times", "article_metadata": {"description": "Also, Soon-Shiong pulls in huge 2015 paycheck, Anthem remains bullish on Obamacare and Microsoft wants to store massive amounts of data on long-lasting DNA strands.", "generator": "WordPress 4.5.2", "og": {"site_name": "MedCity News", "description": "Also, Soon-Shiong pulls in huge 2015 paycheck, Anthem remains bullish on Obamacare and Microsoft wants to store massive amounts of data on long-lasting DNA strands.", "title": "Morning Read: Abbott will acquire cardiac device maker St. Jude Medical in $25B deal", "locale": "en_US", "image": "http://medcitynews.com/wp-content/uploads/2016/04/Illinois_AbbottPark_ML_large.jpg", "updated_time": "2016-04-28T07:55:02-04:00", "url": "http://medcitynews.com/2016/04/abbott-laboratories-and-st-jude-medical/", "type": "article"}, "twitter": {"image": "http://medcitynews.com/wp-content/uploads/2016/04/Illinois_AbbottPark_ML_large.jpg", "creator": "@nversel", "description": "Also, Soon-Shiong pulls in huge 2015 paycheck, Anthem remains bullish on Obamacare and Microsoft wants to store massive amounts of data on long-lasting DNA strands.", "card": "summary", "title": "Morning Read: What were people thinking when they backed Theranos? Could it get worse for Valeant?"}, "robots": "noodp", "fb": {"app_id": 148725768475669}, "google-site-verification": "xudQg7nxVR9ifmMTY4Tf-0wVtX9b6rWLQd0utCweGOc", "keywords": "weight loss, obesity, overweight,diabetes,massachusetts,medical devices,obesity,startups,healthcare innovation, medcity news,medcity news,san francisco, startups, life sciences,accelerator,rock health,startup advice,startup funding,patient monitoring system, motion sensors ,dc,healthcare it,washington,foodborne pathogens, diagnostics company, diagnostic platforms,minimally invasive surgery, laser surgery,cambridge,dealflow,hospitals,wellpoint, healthways, health and wellness, employee wellness programs,investing,wellness,medtronic, shanghai innovation center, china, r&d,china,mdt,minneapolis,minnesota,publics,twin cities,ulcerative colitis, abbott labs, humira,abbott labs,doctors,pharmaceuticals,skin disorders, pharmaceuticals, md anderson cancer center,cancer,texas,renal denervation, st. jude medical,st. jude medical,stj,emr, ehr, electronic health records, electronic medical records, certified emr,certified emr,ehr,electronic health records,electronic medical records,advanced cellular technology,amyotrophic lateral sclerosis,embryonic stem cells,geron corporation,lou gehrig\\'s disease,macular degeneration,regenerative medicine,spinal cord damage,value-based healthcare system, obamacare, fee-for-service model,california,cleveland,health insurance,insurance,ohio,pennsylvania,politics,cancer treatment options library, aetna, aet, healthcare it,aet,aetna,health it,phi,philadelphia,Abbott, medical devices, St. Jude Medical, Theranos, , MedCity News", "article": {"section": "Daily", "tag": "Theranos", "published_time": "2016-04-28T07:55:55-04:00", "modified_time": "2016-04-28T07:55:02-04:00"}, "viewport": "width=device-width,initial-scale=1.0,width=device-width,user-scalable=no,minimum-scale=1.0,maximum-scale=1.0"}, "article_summary": "\u2014 HealthDay via WebMDThe five major health systems in the Milwaukee area have formed an alliance to build the local healthcare workforce.\n\u2014 Business WireTECHNOLOGYMajor health systems share their strategies for fighting ransomware.\n\u2014 STAT, The Wall Street JournalWhile we\u2019re piling on, Pfizer will pay $784.6 million to settle Medicaid fraud charges tied to Wyeth, a company Pfizer bought in 2009.\nTOP STORIESAbbott has agreed to acquire cardiac medical device maker St. Jude Medical in a deal valued at $25 billion.\nThe combined company\u2019s product development pipeline not only includes cardiovascular devices, but also diabetes and neuromodulation patient care."}